Use of cortoss™ as an alternative material in calvarial defects: The first clinical results in cranioplasty

Journal of Craniofacial Surgery

Volumn 19, Issue 1, 2008, Pages 88-95

  Sanus, Galip Zihni ^a   Tanriverdi, Taner ^a,b   Ulu, Mustafa Onur ^a   Kafadar, Ali Metin ^a   Tanriover, Necmettin ^a   Ozlen, Fatma ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alloplastic material; Bone graft; Cortoss ; Cranioplasty; Skull defect

Indexed keywords

BIOMATERIAL; BISPHENOL A BIS(2 HYDROXYPROPYL) ETHER DIMETHACRYLATE; CORTOSS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE GRAFT; BRAIN INFARCTION; CALVARIA; CLINICAL ARTICLE; CRANIOPLASTY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FOREIGN BODY REACTION; GUNSHOT INJURY; HUMAN; INJURY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SKULL DEFECT; SKULL TUMOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; ADOLESCENT; BONE PROSTHESIS; CASE REPORT; CEREBRAL ARTERY DISEASE; CRANIOTOMY; ESTHETICS; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; PATIENT SATISFACTION; PLASTIC SURGERY; PROSPECTIVE STUDY; SAFETY; SKULL; SKULL FRACTURE;

ADOLESCENT; ADULT; BIOCOMPATIBLE MATERIALS; BISPHENOL A-GLYCIDYL METHACRYLATE; BONE SUBSTITUTES; CRANIOTOMY; ESTHETICS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; RECONSTRUCTIVE SURGICAL PROCEDURES; SAFETY; SKULL; SKULL FRACTURES; SKULL NEOPLASMS; TREATMENT OUTCOME; WOUNDS, GUNSHOT;

EID: 38549142554     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/scs.0b013e31815c93fe     Document Type: Article

References (36)

1. Sanan A, Stephen H. Repairing holes in the head: a history of cranioplasty. Neurosurgery 1997;40:588-603
2. Jackson IT, Adham M, Bite U, et al. Update on cranial bone grafts in craniofacial surgery. Ann Plast Surg 1987;18:37-40
3. Prolo DJ, Gutierrez RV, DeVine JS, Oklund SA. Clinical utility of allogeneic skull discs in human craniotomy. Neurosurgery 1984;14:183-186
4. Woodhall B, Spurling RG. Tantalum cranioplasty for war wounds of the skull. Ann Surg 1945;121:649-650
5. Simpson D. Titanium in cranioplasty. J Neurosurg 1965;22:292-293
6. Gosain AK, Persing JA. Biomaterials in the face: benefits and risks. J Craniofac Surg 1999;10:404-414
7. Eppley BL, Hollier L, Stat S. Hydroxyapatite cranioplasty: 2. Clinical experience with a new quick-setting material. J Craniofac Surg 2003;14:209-214
8. Smith AW, Jackson IT, Yousefi J. The use of screw fixation of methylmethacrylate to reconstruct large craniofacial contour defects. Eur J Plast Surg 1999;22:17-21
9. Lara WC, Scheweitzer J, Lewis RP, et al. Technical considerations in the use of polymethylmethacrylate in cranioplasty. J Long Term Effects Med Implants 1998;8:43-53
10. Jasper LE, Deramond H, Mathis JM, et al. The effect of monomer-to-powder ratio on the material properties of cranioplastic. Bone 1999;25:27S-29S
11. Deyerle WM, Crossland S, Sullivan HG. Methylmethacrylate: uses and complications. AORN J 1979;29:696-711
12. Costantino PD, Friedman CD, Jones K, et al. Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg 1992;90:174-185
13. Shapiro SA. Cranioplasty, vertebral body replacement, and spinal fusion with tobramycin-impregnated methylmethacrylate. Neurosurgery 1991;28:789-791
14. Blum KS, Schneider SJ, Rosenthal AD. Methylmethacrylate cranioplasty in children: long-term results. Pediatr Neurosurg 1997;26:33-35
15. Josan VA, Sgouros S, Walsh AR, et al. Cranioplasty in children. Childs Nerv Syst 2005;21:200-204
16. Rubin JP, Yaremchuk MJ. Complications and toxicities of implantable biomaterials used in facial reconstructive and aesthetic surgery: a comprehensive review of the literature. Plast Reconstr Surg 1997;1001:1336-1353
17. Sanuz GZ, Tanriverdi T, Kafadar AM, et al. Use of cortoss for reconstruction of anterior cranial base: a preliminary clinical experience. Eur J Plast Surg 2005;27:371-377
18. Gheduzzi S, Webb JJ, Miles AW. Mechanical characterisation of three percutaneous vertebroplasty biomaterials. J Mater Sci: Mater Med 2006;17:421-426
19. Szpalski M, Gunzburg R, Deramond H. Percutaneous injection of Cortoss synthetic bone void filler in the repair of fractures in the vertebral body. In: Szpalski M, ed. Vertebral osteoporotic compression fractures. Philadelphia: Lippincott, Williams and Wilkins, 2003:171-177
20. Pomrink GJ, DiCicco MP, Clineff TD, et al. Evaluation of the reaction kinetics of Cortoss™ a thermoset cortical bone void filler. Biomaterials 2003;24:1023-1031
21. Hatten HP. Prospective randomized trial of Cortoss versus PMMA in the treatment of vertebral compression fractures; preliminary results at a single center. Las Vegas, USA: American Society of Spine Radiology, 2006
22. Maurer PM, Kim CW, Lieberman I, et al. Treatment of vertebral compression fractures with Cortoss in vertebroplasty and kyphoplasty: one year follow-up. USA: American Society of Spine Radiology, 2006
23. Morgan DR, Kalahandra S, ShobhaHK, et al. Analysis of dimethacrylate copolymer (Bis-GMA and TEGDMA) network by DSC and 13C solution and solid state NMR spectroscopy. Biomaterials 2000;21:1897-1903
24. Yamamuro T, Nakamura T, Iida H, et al. Development of bioactive bone cement and its clinical applications. Biomaterials 1998;19:1479-1482
25. Kawanabe K, Tamura J, Yamamuro T, et al. A new bioactive bone cement consisting of Bis-GMA resin and bioactive glass powder. J Appl Biomaterials 1993;4:135-141
26. Deramond H, Depriester C, Galibert P, et al. Percutaneous vertebroplasty with polymethylmethacrylate, technique, indications, and results. Radiol Clin North Am 1998;36:533-546
27. Heini PF, Berlemann U. Bone substitutes in vertebroplasty. Eur Spine J 2001;10:S205-S213
28. Mehbod A, Aunoble S, Le Huec JC. Vertebroplasty for osteoporotic spine fracture: prevention and treatment. Eur Spine J ;12(Suppl 2):S155-S162
29. Palussiere J, Berge J, Gangi A, et al. Clinical results of an open prospective study of a bis-GMA composite in percutaneous vertebral augmentation. Eur Spine J 2005;14:982-991
30. Andreassen GS, Hoiness PR, Skraamm I, et al. Use of bone void filler to augment screws in osteopenic ankle fracture fixation. Arch Orthop Trauma Surg 2004;124:161-165
31. Luo J, Skrzypiee DM, Pollintine P, et al. Mechanical efficacy of vertebroplasty: influence of cement type, BMD, fracture severity, and disc degeneration. Bone 2007;40:1110-1119
32. Erbe EM, Clineff TD, Gualtieri G. Comparison of a new bisphenol-a-glycidyl dimethacrylate-based cortical bone void filler with polymethyl methacrylate. Eur Spine J 2001;10:S147-S152
33. DiCicco M, Duong T, Chu A. Tobramycine and gentamycine elution analysis between two in situ polymerizable orthopedic composites. Appl Biometer 2003;65B:137-149
34. Evans SL, Hunt CM. Bone cement or bone substitute augmentation of pedicle screws improves pullout strength in posterior spinal fixation. J Mater Sci Mater Med 2002;13:1143-1145
35. DiCicco M, Compton R, Jansen-Vernum SA. In vitro evaluation of orthopedic composite cytotoxicity: assessing the potential for postsurgical production of hydroxyl radicals. J Biomed Mater Res B Appl Biomater 2005;72:146-155
36. Moore DC, Frankenburg EP, Goulet JA, et al. Hip screw augmentation with an in-situ setting calcium phosphate cement: an in vitro biochemical analysis. J Orthop Trauma 1997;11:577-583